STATUTORY RULES.
1959. No. 64.
REGULATIONS
UNDER THE NATIONAL HEALTH ACT 1953-1958.*
I, THE GOVERNOR-GENERAL in and over the
Commonwealth of Australia, acting with the advice of the Federal Executive
Council, hereby make the following Regulations under the National Health Act 1953-1958.
Dated
this 21st day of July, 1959.
W.
J. Slim
Governor-General.
By His
Excellency's Command,
Minister
of State for Health.
Amendments of the National Health
(Pharmaceutical Benefits) Regulations.
Commencement.
1. These Regulations shall come into
operation on the first day of August, 1959.
Pharmaceutical benefits that may
be prescribed only for specified diseases or purposes.
2. Regulation 11 of the National Health
(Pharmaceutical Benefits) Regulations is amended by omitting from
sub-regulation (2.) the words and figures "item 16, 37, 49 or 53" and
inserting in their stead the words and figures "item 1, 10, 16, 37, 49 or
53".
3. After
regulation 11 of the National Health (Pharmaceutical Benefits) Regulations the
following regulation is inserted in Part III.:—
Persons excepted from entitlement
to receive certain forms of pharmaceutical benefits.
"11a. A person who has attained the age of
six years is not entitled to receive a general pharmaceutical benefit (other
than item 5 in the Second Schedule) which is in an oral suspension form or in
granule form.".
Writing of prescriptions.
4. Regulation 17 of the National Health
(Pharmaceutical Benefits) Regulations is amended by omitting from
sub-regulation (4.) the word and figures "or 71" and inserting in
their stead the word and figures", 71 or 76".
Supply of pharmaceutical benefits
on prescriptions.
5. Regulation 20 of the National Health
(Pharmaceutical Benefits) Regulations is amended by omitting from
sub-regulation (2.) the word and figures "or 71" and inserting in
their stead the word and figures", 71 or 76".
Supply of pharmaceutical benefit
before surrender of written prescription.
6. Regulation 21 of the National Health
(Pharmaceutical Benefits) Regulations is amended by omitting from
sub-regulations (2.) and (4.) the word and figures "or 71" (wherever
occurring) and inserting in their stead the word and figures ", 71 or
76".
* Notified in the Commonwealth Gazette on 30th July, 1959.
Statutory Rules 1956, No. 54, as amended by Statutory Rules
1956, No. 75; 1957, Nos. 25 and 52; 1958, No. 23; and 1959, Nos. 4 and 28.
5025/59.—Price
3d. 9/10.7.1959.
First
Schedule.
7. The First Schedule to the National Health
(Pharmaceutical Benefits) Regulations is amended by adding at the end thereof
the following items:—
"174
| Chlorazanil
|
"175
| Sulfadimethoxine
|
176
| Erythrityltetranitrate".
|
Second Schedule.
8. The Second Schedule to the National
Health (Pharmaceutical Benefits) Regulations is amended—
(a)by
omitting item 9;
(b)by
adding at the end of item 11, in the column headed
"Disease or Purpose", the
following words:—
"Bronchiectasis
Fibrocystic diseases of the
pancreas";
(c) by adding at the end of item 12, in the
column headed
"Disease or Purpose" the
following words:—
"Type II nephritis
Cushings syndrome including
hyperadrenocorticalism
Progressive or continuing hepatitis
proven by biopsy or biochemistry";
(d)by omitting item 15 and inserting in its
stead the following item:—
"15
| Deoxycortone Acetate
| Addison's
disease
|
Total
adrenalectomy";
|
(e)by omitting items 20, 21, 32, 40
and 56;
(f)
by omitting item 71 and inserting in its stead the following item:—
"71
| Corticotrophin............................
| Status
asthmaticus
|
Type II
nephritis"; and
|
(g) by adding at the end thereof the following
items:—
"75
| Amphotericin B..........................
| Systemic fungal infection
|
"76
| Dexamethasone..........................
| Any
disease or purpose specified in this column in relation to cortisone acetate
|
"77
| Disodium
Diethylstilboestrol Diphosphate
| Carcinoma of the prostate
|
"78
| Ethinyloestradiol.........................
| Turner's syndrome
|
"79
| Ethisterone.................................
| Turner's syndrome
|
"80
| Fluoxymesterone........................
| Mammary carcinoma
|
"81
| Methyl Androstanolone
| Mammary carcinoma
|
"82
| Pancrex 15.................................
| Any
disease or purpose specified in this column in relation to pancreatin
|
"83
| Tetracycline with Nystatin
| Broad
spectrum antibiotic therapy of premature infants
|
Broad
spectrum antibiotic treatment of patients under steroid therapy
|
Broad
spectrum antibiotic therapy of cases complicated by intestinal moniliasis
|
A
second or repeated course of broad spectrum antibiotic therapy in the
treatment of patients for a disease or purpose specified in this column in
relation to chlortetracycline".
|
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.